CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 63 enrolled
Drug / intervention
Water-Based Vaginal Lubricant +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04038099
NCT04038099Phase 4Completed
CompareCT.gov

Lessons on Urethral Lidocaine in Urodynamics (LULU): Impact of Intraurethral Lidocaine on Cystometric Parameters and Discomfort

University of Texas Southwestern Medical Center·interventional·Posted Jul 30, 2019·Updated Aug 1, 2023

In Brief

A Phase 4 clinical trial evaluating Water-Based Vaginal Lubricant and lidocaine topical for Urethra Issue and 7 related conditions. Completed, enrolled 63 participants across 1 site.

Detailed Summary

This trial will assess whether use of intraurethral 2% lidocaine jelly meaningfully impacts sensation during filling (i.e., a change of more than 25% of first sensation, first desire to void, strong desire to void, or maximum cystometric capacity) and determine whether the use of intraurethral 2% lidocaine jelly meaningfully impacts pain/discomfort, filling metrics, and voiding metrics.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsUrethra Issue, Pelvic Organ Prolapse, Urinary Incontinence, Vaginal Vault Prolapse, Cystocele, Uterine Prolapse, Vaginal Prolapse, Pelvic Floor Disorders
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
2020202120222023202420252026
First PostedJul 30, 2019
Enrollment StartAug 14, 2019
Primary CompletionAug 18, 2021
TodayJul 2, 2026
Enrollment to primary: 2.0 yearsPosted 6.9 years ago

Interventions

Water-Based Vaginal Lubricantdrug

5cc water based jelly applied intraurethral

lidocaine topicaldrug

5cc 2% lidocaine jelly applied intraurethral